Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kami J Maddocks

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Journal of Hematology & Oncology|July 22, 2009
Update in the management of chronic lymphocytic leukemiaKami J Maddocks, Thomas S Lin
Hematology/Oncology Clinics of North America|August 31, 2020
Current Role and Emerging Evidence for Bruton Tyrosine Kinase Inhibitors in the Treatment of Mantle Cell LymphomaDavid A Bond, Kami J Maddocks
Journal of Clinical Medicine|April 3, 2021
Relapsed Mantle Cell Lymphoma: Current Management, Recent Progress, and Future DirectionsDavid A Bond, Peter Martin, Kami J Maddocks
European Biophysics Journal : EBJ|May 8, 2003
Exclusion of maltodextrins from phosphatidylcholine multilayers during dehydration: effects on membrane phase behaviourKaren L Koster, Kami J Maddocks, Gary Bryant
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|August 8, 2018
Cancer-Specific Stress and Trajectories of Psychological and Physical Functioning in Patients With Relapsed/Refractory Chronic Lymphocytic LeukemiaNeha G Goyal, Kami J Maddocks, Amy J Johnson, et al.
Cancer|May 15, 2018
Cells, cytokines, chemokines, and cancer stress: A biobehavioral study of patients with chronic lymphocytic leukemiaBarbara L Andersen, Neha Godiwala Goyal, David M Weiss, et al.
British Journal of Health Psychology|October 5, 2021
Illness representations and psychological outcomes in chronic lymphocytic leukaemiaNicole A Arrato, Thomas R Valentine, John C Byrd, et al.
Blood Advances|May 23, 2024
Acalabrutinib plus venetoclax and rituximab in treatment-naive mantle cell lymphoma: 2-year safety and efficacy analysisMichael Wang, Tadeusz Robak, Kami J Maddocks, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|December 28, 2018
Illness Perceptions in Chronic Lymphocytic Leukemia: Testing Leventhal's Self-regulatory ModelTravis D Westbrook, Eleshia J Morrison, Kami J Maddocks, et al.
Cancer|December 11, 2019
Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 studyJonathon B Cohen, Lai Wei, Kami J Maddocks, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Journal of Hematology & Oncology|July 22, 2009
Update in the management of chronic lymphocytic leukemiaKami J Maddocks, Thomas S Lin
Hematology/Oncology Clinics of North America|August 31, 2020
Current Role and Emerging Evidence for Bruton Tyrosine Kinase Inhibitors in the Treatment of Mantle Cell LymphomaDavid A Bond, Kami J Maddocks
Journal of Clinical Medicine|April 3, 2021
Relapsed Mantle Cell Lymphoma: Current Management, Recent Progress, and Future DirectionsDavid A Bond, Peter Martin, Kami J Maddocks
European Biophysics Journal : EBJ|May 8, 2003
Exclusion of maltodextrins from phosphatidylcholine multilayers during dehydration: effects on membrane phase behaviourKaren L Koster, Kami J Maddocks, Gary Bryant
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|August 8, 2018
Cancer-Specific Stress and Trajectories of Psychological and Physical Functioning in Patients With Relapsed/Refractory Chronic Lymphocytic LeukemiaNeha G Goyal, Kami J Maddocks, Amy J Johnson, et al.
Cancer|May 15, 2018
Cells, cytokines, chemokines, and cancer stress: A biobehavioral study of patients with chronic lymphocytic leukemiaBarbara L Andersen, Neha Godiwala Goyal, David M Weiss, et al.
British Journal of Health Psychology|October 5, 2021
Illness representations and psychological outcomes in chronic lymphocytic leukaemiaNicole A Arrato, Thomas R Valentine, John C Byrd, et al.
Blood Advances|May 23, 2024
Acalabrutinib plus venetoclax and rituximab in treatment-naive mantle cell lymphoma: 2-year safety and efficacy analysisMichael Wang, Tadeusz Robak, Kami J Maddocks, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|December 28, 2018
Illness Perceptions in Chronic Lymphocytic Leukemia: Testing Leventhal's Self-regulatory ModelTravis D Westbrook, Eleshia J Morrison, Kami J Maddocks, et al.
Cancer|December 11, 2019
Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 studyJonathon B Cohen, Lai Wei, Kami J Maddocks, et al.
Pageof 5